Article
EGFR transactivates RON to drive oncogenic crosstalk.
eLife - 25 Nov 2021
Franco Nitta Carolina, Green Ellen W, Jhamba Elton D, Keth Justine M, Ortiz-Caraveo Iraís, Grattan Rachel M, Schodt David J, Gibson Aubrey C, Rajput Ashwani, Lidke Keith A, Wilson Bridget S, Steinkamp Mara P, Lidke Diane S
Abstract excerpt
Crosstalk between different receptor tyrosine kinases (RTKs) is thought to drive oncogenic signaling and allow therapeutic escape. EGFR and RON are two such RTKs from different subfamilies, which engage in crosstalk through unknown mechanisms. We combined high-resolution imaging with biochemical and mutational studies to ask how EGFR and RON communicate. EGF stimulation promotes EGFR-dependent phosphorylation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
